Does Medtech Have an Appetite for M&A?—Hologic

"Yes we are ready and willing to spend there on M&A and actually we did make an acquisition of our own stock in the quarter. That was actually a pretty good acquisition that we made and we are feeling pretty good about that.

The teams are definitely looking and where Bob and Eric and I are now reviewing on a more regular basis ideas . . . Ultimately I look forward to the day that we have no converts left on the balance sheet, but I would suspect we will be doing some acquisitions along the way while we continue to clean those up.

So, still in the way at this point in time still focusing the division on what we call bite size, things that supplement the existing businesses and we are very willing and ready to go, but . . . nothing imminent wouldn't even necessarily expect any, anything much in this fiscal year necessarily. So we thought mop up some share as well that the market gave us a nice opportunity."

Steve MacMillan, Hologic chairman, president, and CEO, according to a Seeking Alpha transcript of the company's fiscal second quarter earnings call.

Get inspired to innovate in medtech at the MD&M East Conference, June 14-16, in New York City.